METIS: Pivotal, open-label, randomized study of radiosurgery with or without Tumor Treating Fields (TTFields) for 1-10 brain metastases from non-small cell lung cancer (NSCLC)
A study for patients with brain metastases from non-small cell lung cancer (NSCLC) using radiosurgery
Sponsor: NovoCure Ltd.
Enrolling: Male and Female Patients
IRB Number: AAAR1011
U.S. Govt. ID: NCT02831959
Contact: Teri Kreisl: 212-342-0571 / tnk2109@cumc.columbia.edu
Additional Study Information: The purpose of this study is to obtain information on the safety and effectiveness of NovoTTF-100M (study device) in subjects with brain metastases (tumors) as a result of non-small cell lung cancer (NSCLC).
This study is closed
Investigator
Teri Kreisl, MD
Do You Qualify?
Have you been diagnosed with a brain tumor as a result of having NSCLC? Yes No
Are you at least 18 years of age? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Teri Kreisl
tnk2109@cumc.columbia.edu
212-342-0571
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE